Bristol-Myers Squibb Awards PanTher with ‘Golden Ticket’ for LabCentral
Bristol-Myers Squibb Company and LabCentral, an innovative, shared laboratory space designed as a launch pad for life-sciences and biotech startups, today announced that PanTher is one of the winners of Bristol-Myers Squibb’s Golden Tickets for LabCentral. As a platinum sponsor of LabCentral, Bristol-Myers Squibb can select up to two innovative life-sciences and biotech startup companies per year of active sponsorship for “Golden Tickets,” which underwrite the cost of one lab bench for one year in LabCentral’s Kendall Square facility.
A Simple Piece of Plastic Could Slash Pancreatic Cancer Death Rates
The pancreas is located in the middle of a person’s belly, surrounded by other vital organs like the liver and stomach. This both makes it extremely hard for surgeons to remove the tumor and easier for it to metastasize and spread. Chemotherapy–which sends toxic drugs throughout the body to reach the tumor site–is still often the only option, and it’s not even very effective because pancreatic tumors have few blood vessels to take up the drugs. “To me, it seems very counterintuitive to have a whole body treatment to target a specific organ,” says CEO Dr. Laura Indolfi.
How This Entrepreneur Is Revolutionizing the Way We Treat Cancer
By the time pancreatic cancer is diagnosed, the tumors often are too large to be surgically removed. Doctors use chemotherapy to try to shrink them, but because the pancreatic tumor doesn’t have that many blood vessels, the drugs don’t often reach the tumor in the desired concentration. Biomedical engineer Dr. Laura Indolfi envisions a drug-infused bandage that can be wrapped around a tumor to solve this problem. “A lot of money has been spent, and a lot of research done, to find a new powerful agent for pancreatic cancer. But there aren’t enough blood vessels inside. It’s wrong for this type of tumor. The drug will go everywhere else.”
An entrepreneur with a novel approach to fighting cancer
PanTher founder and CEO Laura Indolfi was interviewed by Fortune’s Adam Lashinsky for an article in the Tech Data Sheet titled “An entrepreneur with a novel approach to fighting cancer.” The article previewed Dr. Indolfi’s upcoming presentation at TED in Vancouver, and highlighted the vision behind PanTher Therapeutics and the unique approach the company is taking to fighting solid tumors.
PanTher Therapeutics’ CEO, Dr. Laura Indolfi, Named a TED Fellow
Laura Indolfi, co-founder & CEO of PanTher Therapeutics has been selected as a TED Fellow, joining a class of 21 change-makers from around the world who will share their ideas worth spreading from the TED stage this February in Vancouver. The TED Fellows program brings together young innovators from around the world and across disciplines, who display both outstanding achievement and exemplary character, to ignite their careers.
PanTher Therapeutics Selected to Participate in MassCONNECT Showcase
MassCONNECT, the only entrepreneur mentorship program in Massachusetts that dives deep into the life sciences industry, has picked PanTher to participate in the 4th cycle of his program. Sponsored by Boehringer Ingelheim and Nixon Peabody LLP, the mentoring will take place in the offices of MassBio.